Navigation Links
Ironwood and Forest to Present Positive Data From Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
Date:9/23/2008

- Comprehensive Phase 3 Clinical Program Initiated -

CAMBRIDGE, Mass. and NEW YORK, Sept. 23 /PRNewswire-FirstCall/ -- Ironwood Pharmaceuticals (formerly Microbia) and Forest Laboratories, Inc. (NYSE: FRX) today announced they will present results of a Phase 2b study investigating linaclotide's safety and efficacy in 419 patients with irritable bowel syndrome with constipation (IBS-C) in a plenary session at the American College of Gastroenterology (ACG) 2008 Annual Scientific Meeting in Orlando, Fla. on October 7, 2008. Analysis of these data indicated that the study met its primary endpoint. Linaclotide is a first-in-class investigational compound being evaluated for its potential to treat IBS-C, chronic constipation (CC), and other gastrointestinal disorders.

(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )

Ironwood and Forest also announced that they have initiated a comprehensive Phase 3 clinical program to evaluate linaclotide's safety and efficacy in patients with either IBS-C or CC. The program will include two pivotal trials in IBS-C patients and two pivotal trials in CC patients, enrolling over 2,500 patients at approximately 250 clinical centers. The companies recently began patient dosing in the first CC trial and expect to initiate the second CC trial by the end of September, 2008. The companies expect to initiate both IBS-C trials by January, 2009.

IBS-C Phase 2b Study

This U.S. and Canada based, twelve-week, randomized, double-blind, placebo-controlled Phase 2b study was designed to assess the safety, efficacy, and dose-response of linaclotide in patients with IBS-C. Patients were ran
'/>"/>

SOURCE Ironwood Pharmaceuticals; Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
2. Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
3. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
4. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
5. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
6. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
7. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
8. Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America
9. ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple Sclerosis
10. New Data Presented at WCTRIMS* Supports the Importance of Early and Sustained Treatment with Betaseron(R)
11. NOVAVAX CEO to Present at 2008 UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... ALTO, Calif. , Sept. 30, 2014 /PRNewswire/ ... investment group focused on supporting promising emerging biotech, ... has been named the Top Angel Investment Group ... Insights as the best performer out of 370 ... included: historical performance, network strength (connections), selection aptitude ...
(Date:9/30/2014)... 2014 Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology, announced today that ... a finalist in the Diagnostics & Research Tools ... Awards, sponsored by CONNECT. CONNECT, a regional program that ... sciences products in San Diego County ...
(Date:9/30/2014)... Inc. ( www.synapsebiomedical.com ) announced today it has ... its NeuRx DPS® System for ALS patients.  The ... requirement was implanted over a month and a ... is the only medical device approved by the ... device that obtained approval at the end of ...
Breaking Medicine Technology:Life Science Angels Ranked the Top Angel Investment Group in the U.S. 2Life Science Angels Ranked the Top Angel Investment Group in the U.S. 3Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 2Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 3
... CHICAGO, May 16, 2012 /PRNewswire-iReach/ -- Chronic ... most common causes of persistent, debilitating back pain. Chicago ... compromised his livelihood and soured his outlook on life. ... many doctors, he finally found relief with non-surgical treatment ...
... The sleep apnea diagnostics devices market has witnessed ... caused by improved awareness. The market is currently in ... largely dependent on the degree of awareness of sleep ... Frost & Sullivan ( http://www.patientmonitoring.frost.com ), Strategic Analysis ...
Cached Medicine Technology:The Illinois Back Institute Helps Patient Beat Debilitating Back Pain 2Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan 2Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan 3
(Date:9/30/2014)... Jose, California (PRWEB) September 30, 2014 ... are organic compounds, which are mixed with animal feed ... weight gain, and improve gut health and digestion. Amidst ... milk, eggs and meat across the globe, the need ... and aquaculture sectors is on the rise, thereby driving ...
(Date:9/30/2014)... Eastern Finland shows that dietary polyunsaturated fatty acids may ... of polyunsaturated fatty acids include fish, vegetable oils, and ... & Vascular Biology , an esteemed journal of the ... an association between the consumption of saturated fats and ... mere reduction of saturated fats from the diet does ...
(Date:9/30/2014)... Amy Norton ... News) -- Long-acting contraceptive devices should be the first ... from the American Academy of Pediatrics state. Although ... pills, two other forms of contraception -- intrauterine devices ... according to the academy. And they should be ...
(Date:9/30/2014)... Visit Pam and Steve’s quiet home in ... find a loving couple facing the most monumental challenge ... , Steve was diagnosed with ALS – more commonly ... before the couple’s second wedding anniversary. Pam is ... “Care, Support & ALS,” that’s part of ...
(Date:9/30/2014)... Neuromuscular and central nervous system ... States and worldwide. It is estimated that 50,000-60,000 ... year, adding to the more than one million ... people in the US are affected by Multiple ... statistics the 2.4 percent of the US population ...
Breaking Medicine News(10 mins):Health News:Rising Consumption of Meat and Meat Products to Fuel Growth in the Global Feed Acidifiers Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Rising Consumption of Meat and Meat Products to Fuel Growth in the Global Feed Acidifiers Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Dietary polyunsaturated fatty acids linked to smaller risk of coronary heart disease 2Health News:Pediatricians Endorse IUDs, Implants for Teen Birth Control 2Health News:Pediatricians Endorse IUDs, Implants for Teen Birth Control 3Health News:Hospice Provides Care and Support to Patients and Family Caregivers with ALS 2Health News:North American Seminars Introduces a New OT PT CME Course, Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy 2Health News:North American Seminars Introduces a New OT PT CME Course, Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy 3
... Research, Inc.,(Scimitar) issues a review of StatSure Diagnostic ... for Investors Seeking,to Participate In a Proprietary Point-of-Care ... website: http://www.scimitarequity.com . ABOUT STATSURE ... development,manufacture and marketing of rapid immunoassay tests for ...
... Valve Repair Product Portfolio, MINNEAPOLIS, Oct. ... ), manufacturer and marketer of state-of-the-art cardiac,surgery ... and Drug,Administration (FDA) clearance for the ATS ... the next in a series of,mitral valve ...
... to Provide Funding and Support for "Patient Navigator,Program" ... Everett, Washington, EVERETT, Wash., Oct. 25 ... new Patient Navigator Program at,the Providence Regional Cancer ... one part of a strategic nationwide effort to,significantly ...
... for interviews, OAKLAND, Calif., Oct. 25 ... volunteer,registered nurses through its Registered Nurse Response Network ... the spreading disaster,created by wildfires in the region. ... to shelters in San Diego,County in response to ...
... House Republican Whip,Roy Blunt (Mo.) issued the following ... children,s health program created by,Republicans to expand taxpayer-funded care ... in some cases, not even in this country legally:, ... take our concerns to heart and,come back with an ...
... 25 Darwin,Professional Underwriters, Inc. (Darwin) (NYSE: ... its third quarter 2007 financial results following the,close ... conference call to,discuss the company,s third quarter 2007 ... 2007 at 8:00 a.m. Eastern Time. (Logo: ...
Cached Medicine News:Health News:StatSure Diagnostic Systems, Inc. (OTC Bulletin Board: SSUR) Review Issued By Scimitar Equity Research, Inc. 2Health News:ATS Medical Receives FDA Clearance for ATS Simulus Semi-Rigid Annuloplasty Ring 2Health News:ATS Medical Receives FDA Clearance for ATS Simulus Semi-Rigid Annuloplasty Ring 3Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 2Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 3Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 4Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 5Health News:CNA/NNOC Nurse Volunteers Deployed to Southern California Firestorm 2Health News:Darwin to Announce Third Quarter 2007 Financial Results 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: